Tyche Wealth Partners LLC decreased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 22.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,902 shares of the biotechnology company's stock after selling 545 shares during the period. Tyche Wealth Partners LLC's holdings in Axon Enterprise were worth $1,574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. TCTC Holdings LLC grew its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after acquiring an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC grew its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new stake in shares of Axon Enterprise during the 1st quarter valued at $32,000. Banque Transatlantique SA bought a new stake in shares of Axon Enterprise during the 1st quarter valued at $31,000. Finally, Flaharty Asset Management LLC bought a new stake in shares of Axon Enterprise during the 1st quarter valued at $33,000. Institutional investors own 79.08% of the company's stock.
Insider Buying and Selling at Axon Enterprise
In related news, Director Hadi Partovi acquired 1,358 shares of the company's stock in a transaction on Wednesday, August 13th. The stock was acquired at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the acquisition, the director directly owned 237,938 shares of the company's stock, valued at approximately $176,074,120. This trade represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company's stock, valued at $108,417,953.80. This trade represents a 5.18% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,932 shares of company stock worth $37,978,216. Insiders own 4.40% of the company's stock.
Wall Street Analysts Forecast Growth
AXON has been the subject of a number of recent research reports. JMP Securities reissued a "market outperform" rating and set a $825.00 price objective on shares of Axon Enterprise in a research report on Monday, September 29th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Axon Enterprise in a report on Saturday, September 27th. Zacks Research downgraded shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Piper Sandler started coverage on shares of Axon Enterprise in a report on Tuesday, September 23rd. They issued an "overweight" rating and a $893.00 target price for the company. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $841.64.
Get Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Trading Up 0.8%
Shares of Axon Enterprise stock opened at $721.59 on Tuesday. The company has a market capitalization of $56.65 billion, a P/E ratio of 178.17, a P/E/G ratio of 27.79 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The company has a fifty day moving average of $757.50 and a 200 day moving average of $710.51. Axon Enterprise, Inc has a fifty-two week low of $416.88 and a fifty-two week high of $885.91.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the firm earned $1.20 EPS. The business's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.